New Developments in the Treatment of ADHD: (Academic Highlights)
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Article AbstractClick to enlarge pageIntroducing the topic, Joseph Biederman, M.D., explained that new developments in the treatment of attention-deficit/hyperactivity disorder (ADHD) include more than useful medications. New developments relate to recent neurobiological research findings, research on comorbid diagnoses, explanations of drug mechanisms of action, nonpharmacologic treatment recommendations, and the role that primary care physicians play in treatment of the disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barkley, R. A., Fischer, M., Smallish, L., & Fletcher, K. (2002) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.111.2.279 · Cited by 1,199
Bymaster, F. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00346-9 · Cited by 1,123
Solanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1088 · Cited by 652
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.11.1652 · Cited by 528
Self-citationCognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms
Safren, S. A., Otto, M. W., Sprich, S., Winett, C. L., Wilens, T. E., & Biederman, J. (2005) · Behaviour Research and Therapy · doi:10.1016/j.brat.2004.07.001 · Cited by 519
Self-citationWolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404
Self-citationIssues of taxonomy and comorbidity in the development of conduct disorder
Hinshaw, S. P., Lahey, B. B., & Hart, E. L. (1993) · Development and Psychopathology · doi:10.1017/s0954579400004247 · Cited by 384
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder
CONNOR, D. F., FLETCHER, K. E., & SWANSON, J. M. (1999) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199912000-00017 · Cited by 297
A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder
Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., & Stevenson, R. J. (2002) · Australian & New Zealand Journal of Psychiatry · doi:10.1046/j.1440-1614.2002.01052.x · Cited by 261
Cited by
Chamberlain, S. R., Hampshire, A., Müller, U., Rubia, K., del Campo, N., Craig, K., Regenthal, R., Suckling, J., Roiser, J. P., Grant, J. E., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.10.014 · Cited by 301
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
“Thus, the most effective drugs used to treat ADHD, such as methylphenidate and d-amphetamine, are all stimulants, which increase levels of dopamine and norepinephrine to enhance catecholamine signalling in the brain [150,151].”
BackgroundChamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178
Groman, S. M., James, A. S., & Jentsch, J. D. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.008 · Cited by 177
“Amongst neuropsychiatric disorders, ADHD is somewhat unique in that the available pharmacological treatments, while not without side effects, are remarkably effective at controlling symptomatology (Arnsten 2006b; Biederman et al. 2006).”
BackgroundDramsdahl, M., Westerhausen, R., Haavik, J., Hugdahl, K., & Plessen, K. J. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2011.08.005 · Cited by 66
Metadata
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-01-15
- Volume
- 67
- Issue
- 01
- Pages
- 148-159
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W164878589
- Cited by
- 32
- References
- 12
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: New Developments in the Treatment of ADHD: (Academic Highlights). https://app.cochat.ai/papers/10.4088/jcp.v67n0121
- The paper
- New Developments in the Treatment of ADHD: (Academic Highlights). (2006). The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v67n0121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.